Myasthenia gravis constitutes chronic autoimmune ailment that primarily targets the neuromuscular junction. This junction mediates the conveyance of signals from nerves to muscles, enabling movement. In myasthenia gravis, the body's immune system mistakenly attacks these receptors, leading weakness and fatigue in the muscles. The manifestations of